RYTM icon

Rhythm Pharmaceuticals
RYTM

Overview Fund Activity

115 hedge funds and large institutions have $1.81B invested in Rhythm Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 12 closing their positions.

Holders
115
Holders Change
+14
Holders Change %
+13.86%
% of All Funds
1.86%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
26
Increased
42
Reduced
28
Closed
12
Calls
$15.5M
Puts
$12.9M
Net Calls
+$2.66M
Net Calls Change
-$18.2M

Top Buyers

1
PCH
1
Polar Capital Holdings
United Kingdom
$36.4M
2
Alkeon Capital Management
2
Alkeon Capital Management
New York
$65.2M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$20.2M
4
Goldman Sachs
4
Goldman Sachs
New York
$151M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$75.6M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$36.1M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$22.5M
3
Walleye Capital
3
Walleye Capital
New York
$0
4
Primecap Management
4
Primecap Management
California
$201M
5
CSS
5
Cubist Systematic Strategies
Connecticut
$481K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of Montreal
126
Bank of Montreal
Ontario, Canada
– -$14 -567 Closed
HFS
127
Hantz Financial Services
Michigan
– -$3K -115 Closed
2 3 4 5
6